Caracterización de la funcionalidad y el fenotipo de linfocitos T CD8+ en individuos HIV-1 positivos bajo tratamiento antirretroviral combinado
Several strategies have been proposed in the quest for an HIV cure, many rely on CD8+ T cells (CD8TC) antiviral activity. In this thesis, the functionality and phenotype of in vitro expanded HIV-specific CD8TC, obtained from HIV+ subjects on combined antiretroviral treatment (cART), was investigated...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Tesis doctoral acceptedVersion |
| Lenguaje: | Español |
| Publicado: |
Facultad de Farmacia y Bioquímica
2019
|
| Materias: | |
| Acceso en línea: | http://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=posgraafa&cl=CL1&d=HWA_2824 http://repositoriouba.sisbi.uba.ar/gsdl/collect/posgraafa/index/assoc/HWA_2824.dir/2824.PDF |
| Aporte de: |
| Sumario: | Several strategies have been proposed in the quest for an HIV cure, many rely on CD8+ T cells (CD8TC) antiviral activity. In this thesis, the functionality and phenotype of in vitro expanded HIV-specific CD8TC, obtained from HIV+ subjects on combined antiretroviral treatment (cART), was investigated. According to the momento of cART initiation, two groups were recruited: early treatment (TTe) or delayed treatment (TTa) groups. Peripheral blood mononuclear cells were obtained and expanded using Nef and Gag peptide pools. Post-expansion, CD8TC specificity, functionality, memory phenotype differentiation, PD-1 expression, as well as antiviral activity were assessed. Even though, post-cART HIV specific immune response results deeply diminished, it could be selectively expanded, demonstrating a polifunctional and effector memory/effector profiles, as well as strong antiviral activity. Differences in cART initiation timing affected mainly memory phenotype differentiation, possibly reflecting the impact of antigenic stimulation on the immune system. In both groups, characteristics of the immune response observed before cART could be proposed as biomarkers of the functionality of CD8TC that persist post-cART. In sum, these results have important implications in the design of strategies aimed at boosting CD8TC beneficial responses. |
|---|